Access Vascular to Ramp Production With $22 Million Series C Financing
Funding to drive production scale-up and expansion of MIMIX™ biomaterial catheter portfolio, increased R&D
BILLERICA, Mass.–(BUSINESS WIRE)–Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications with its advanced biomaterial platform, today announced that it raised a Series C round worth $22 million from a consortium of new and existing investors.
